Neuropace
NPCE
NPCE
39 hedge funds and large institutions have $177M invested in Neuropace in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $259M → $177M (-$82M)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.53M | |
| 2 | +$1.81M | |
| 3 | +$1.78M | |
| 4 |
Amundi
Paris,
France
|
+$1.29M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$410K |
Top Sellers
| 1 | -$5.45M | |
| 2 | -$952K | |
| 3 | -$952K | |
| 4 |
Millennium Management
New York
|
-$773K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$555K |